However, granzyme B expression was significantly higher in Eomes + Tbet + Mtb-specific IFNγ+CD4+ T cells in patients with TB-IRIS compared to non-IRIS controls at week 2 on ART (median: 4.7% vs 0%, respectively; P = .026). The gene discussed is GZMB; the disease is tuberculosis.